BioCentury | Jan 8, 2021
Deals

ArsenalBio reaches next stage of maturity with BMS deal

...of technologies from six co-founders and an $85 million in a series A round from Westlake Village BioPartners...
BioCentury | Dec 16, 2020
Emerging Company Profile

With crossover funding already in place, Stagliano’s Neuron23 exits stealth with programs in neurology, systemic immune disease

...2017, Neuron23 Inc. won the backing of Westlake Village BioPartners...
...GmbHNumber of employees: 14Funds raised: $113.5 millionInvestors: Westlake Village BioPartners...
...kinase 2TYK2 – Tyrosine kinase 2 Paul Bonanos Origenis GmbH Westlake Village Biopartners Kleiner...
BioCentury | Dec 15, 2020
Finance

Westlake aims to strengthen L.A.-area biotech ecosystem with pair of new funds, new immunology launch

...it prepares to deploy two new funds, Westlake Village BioPartners...
...the first flagship fund to the new Westlake Village BioPartners...
...targets implicated in both neurology and immunology. Paul Bonanos Westlake Village Biopartners Acelyrin...
BioCentury | Mar 10, 2020
Politics, Policy & Law

We’ve moved on from nude women parties. The progress is much bigger than that.

...investment firm together with Amgen Inc. (NASDAQ:AMGN) veteran Sean Harper, raising $320 million to start Westlake Village BioPartners...
BioCentury | Feb 21, 2020
Product Development

T regs are back - promising to do for autoimmunity what CAR Ts have done in cancer

...Therapeutics Inc. launched in January with a $25 million series A round from Vida Ventures, Westlake Village Biopartners...
BioCentury | Jan 14, 2020
Emerging Company Profile

Kyverna applies Tregs, CAR Ts to autoimmune diseases with $25M series A, Gilead deal

...on Monday with a $25 million series A round from founding investors Vida Ventures and Westlake Village BioPartners...
BioCentury | Nov 19, 2019
Politics & Policy

Investors sound alarm about pending drug pricing legislation

...managing partner, Scott Ryles, COO, Agnes So, VP of finance, and Desmond Padhi, associate partner, Westlake Village BioPartners...
BioCentury | Nov 2, 2019
Finance

American Cancer Society’s BrightEdge venture fund hoping to do well by doing good

...top-tier VCs in highly regarded, well-financed biopharma companies. For example, BrightEdge participated alongside Andreessen Horowitz, Westlake Village BioPartners...
BioCentury | Nov 1, 2019
Emerging Company Profile

Tmunity: Manufacturing momentum for CAR and TCR therapies

...and blood tumors. Andreessen Horowitz (a16z) led the financing, which saw participation from existing investor Westlake Village BioPartners...
...N/A Number of employees: 47 Funds raised: $231 million Investors: Andreessen Horowitz, Ping An Ventures, Westlake Village BioPartners...
BioCentury | Oct 17, 2019
Emerging Company Profile

Parker Institute’s ArsenalBio launches with $85M to build cell engineering war chest

...Inc. and T cell imaging biotech ImaginAb Inc. Beth Seidenberg, managing director of ArsenalBio investor Westlake Village BioPartners...
...Sean Parker and investigators from the institute’s affiliate institutions around the country. In addition to Westlake Village BioPartners...
...University of Pennsylvania Corporate partners: None Number of employees: Undisclosed Funds raised: $85 million Investors: Westlake Village BioPartners...
Items per page:
1 - 10 of 14
BioCentury | Jan 8, 2021
Deals

ArsenalBio reaches next stage of maturity with BMS deal

...of technologies from six co-founders and an $85 million in a series A round from Westlake Village BioPartners...
BioCentury | Dec 16, 2020
Emerging Company Profile

With crossover funding already in place, Stagliano’s Neuron23 exits stealth with programs in neurology, systemic immune disease

...2017, Neuron23 Inc. won the backing of Westlake Village BioPartners...
...GmbHNumber of employees: 14Funds raised: $113.5 millionInvestors: Westlake Village BioPartners...
...kinase 2TYK2 – Tyrosine kinase 2 Paul Bonanos Origenis GmbH Westlake Village Biopartners Kleiner...
BioCentury | Dec 15, 2020
Finance

Westlake aims to strengthen L.A.-area biotech ecosystem with pair of new funds, new immunology launch

...it prepares to deploy two new funds, Westlake Village BioPartners...
...the first flagship fund to the new Westlake Village BioPartners...
...targets implicated in both neurology and immunology. Paul Bonanos Westlake Village Biopartners Acelyrin...
BioCentury | Mar 10, 2020
Politics, Policy & Law

We’ve moved on from nude women parties. The progress is much bigger than that.

...investment firm together with Amgen Inc. (NASDAQ:AMGN) veteran Sean Harper, raising $320 million to start Westlake Village BioPartners...
BioCentury | Feb 21, 2020
Product Development

T regs are back - promising to do for autoimmunity what CAR Ts have done in cancer

...Therapeutics Inc. launched in January with a $25 million series A round from Vida Ventures, Westlake Village Biopartners...
BioCentury | Jan 14, 2020
Emerging Company Profile

Kyverna applies Tregs, CAR Ts to autoimmune diseases with $25M series A, Gilead deal

...on Monday with a $25 million series A round from founding investors Vida Ventures and Westlake Village BioPartners...
BioCentury | Nov 19, 2019
Politics & Policy

Investors sound alarm about pending drug pricing legislation

...managing partner, Scott Ryles, COO, Agnes So, VP of finance, and Desmond Padhi, associate partner, Westlake Village BioPartners...
BioCentury | Nov 2, 2019
Finance

American Cancer Society’s BrightEdge venture fund hoping to do well by doing good

...top-tier VCs in highly regarded, well-financed biopharma companies. For example, BrightEdge participated alongside Andreessen Horowitz, Westlake Village BioPartners...
BioCentury | Nov 1, 2019
Emerging Company Profile

Tmunity: Manufacturing momentum for CAR and TCR therapies

...and blood tumors. Andreessen Horowitz (a16z) led the financing, which saw participation from existing investor Westlake Village BioPartners...
...N/A Number of employees: 47 Funds raised: $231 million Investors: Andreessen Horowitz, Ping An Ventures, Westlake Village BioPartners...
BioCentury | Oct 17, 2019
Emerging Company Profile

Parker Institute’s ArsenalBio launches with $85M to build cell engineering war chest

...Inc. and T cell imaging biotech ImaginAb Inc. Beth Seidenberg, managing director of ArsenalBio investor Westlake Village BioPartners...
...Sean Parker and investigators from the institute’s affiliate institutions around the country. In addition to Westlake Village BioPartners...
...University of Pennsylvania Corporate partners: None Number of employees: Undisclosed Funds raised: $85 million Investors: Westlake Village BioPartners...
Items per page:
1 - 10 of 14